Search

everythinglearnresearchcommunity

for

Search:↓

An elderly man's hair grew back after treatment with secukinumab, possibly due to reduced scalp inflammation or the medication's direct effects.

Tofacitinib significantly improved symptoms in a patient with overlapping autoimmune disorders.

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

Agalsidase alfa helps treat Fabry's disease but needs more research for long-term benefits.

A patient with alopecia had hair regrowth with tofacitinib but developed a skin reaction, choosing to continue the treatment despite the side effect.

Fish oil increased cell growth and macrophages in the skin but didn't affect COX-2 expression.

Effective management of side effects is crucial for safe use of sacituzumab govitecan in advanced breast cancer treatment.

A rash from semaglutide may be due to propylene glycol, not the drug itself.

Early diagnosis and treatment are crucial for CAPS, and Eculizumab can be effective.

Dupilumab improves skin microbiome balance in atopic dermatitis patients.

A patient with Crohn's disease grew back their hair after stopping Adalimumab, which had caused hair loss.

Mogamulizumab treatment in Sézary syndrome may cause skin issues and hair loss but can lead to a complete response.

Most patients successfully switched from the original adalimumab to a biosimilar with few reverting due to reduced effectiveness or side effects.

Tofacitinib effectively treated a woman's complex autoimmune and autoinflammatory disorders.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

Adalimumab can cause hair loss and scalp issues in some psoriasis patients.

Upadacitinib effectively treats skin conditions like eczema and psoriasis and is becoming more widely used and affordable.

Combining delgocitinib ointment with excimer laser can effectively treat severe alopecia areata.

Anti-CD19 therapy may help treat SLE and NMOSD.

Risankizumab may help manage symptoms of dissecting cellulitis of the scalp.

Dupilumab effectively improves skin conditions, reduces symptoms, and enhances quality of life in certain dermatological issues.

Biologics, especially Dupilumab, are effective and safe for treating severe childhood eczema.

TAK-279 effectively reduces psoriasis symptoms and is safe.

Adalimumab effectively stabilized severe folliculitis decalvans, preventing further hair loss and inflammation.

Recognizing unusual symptoms in Crohn's disease is crucial for proper treatment.

Gujian oral liquid reduces osteoarthritis symptoms by targeting inflammation.